BioPharma Services

Every Patient Counts

Drug development and companion diagnostics require a quality lab partner. Our state-of-the-art laboratory and professional services can help you develop and validate custom assays designed to provide much-needed therapies to those impacted by cancer and a wide range of hereditary disorders.

When the approval of your drug or therapy is pending the proper identification of patients, Ambry’s experience in genetic testing can be the life-giving solution. Utilizing a secondary orthogonal confirmatory testing method is crucial to hitting the expected drug performance characteristics.

Our Services

Ambry can be your partner for a range of services from designing your clinical test menu and custom assays to biomarker discovery and In Vitro Diagnostics (IVD). In addition our tests can be applied to a wide variety of Hereditary and Somatic conditions.

Somatic Tumor Molecular- Germline
Oncology Oncology
Immuno-Oncology Cardiology
  Rare and Orphan Diseases

Facility Overview

Ambry’s CLIA-approved CAP-certified, New York approved lab boasts more than 65,000 sq. feet of highly-automated equipment, optimized for everything from large scale, volume testing to customized research projects. Our comprehensive end-to-end Precision Medicine workflow includes the following platforms:

  • Next-generation sequencing (NGS)
    • Exome
    • Custom Panels
  • Sanger sequencing
  • Paired Normal Tumor testing
  • PCR (Polymerase Chain Reaction)
  • SNP Array/Mass Array/GWAS Array
  • Functional Assays

Quality. Experience. Expertise.

Ambry has a department of professionals dedicated to managing and administering key elements of our Quality Management System (QMS). We maintain our Service Organization Control (SOC2) Certification through the implementation of strict guidelines for:

  • Licensure & credentialing
  • Disaster recovery
  • Proficiency testing
  • Document control
  • Training & competency
  • Sample chain of custody

All Ambry tests are developed and validated in full compliance with all federal, state and local laws, rules and regulations; including CLIA, New York State and CAP standards. Our test performance is routinely and closely monitored to ensure the timely delivery of accurate test results to our clients and their patients.

Have a Project in Mind?

Contact Us
500+ Diagnostic Genetic
Tests to Market

Search Results

Start your search...